Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-04-12 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2021年限制性股票激励计划授予价格调整及预留部分授予相关事项的法律意见书
Governance Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the adjustment of grant prices and reserved portion grants under a 2021 restricted stock incentive plan of Shenzhen Huitai Medical Devices Co., Ltd. It discusses legal compliance, approvals, authorizations, and conditions related to the stock incentive plan. The document references relevant laws, regulations, and company resolutions but does not contain financial statements or earnings data. It is a legal and governance-related document focused on stock incentive plan implementation and compliance, not a financial report or earnings release. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing internal rules, board structure, and governance practices related to stock incentive plans and corporate governance matters.
2022-04-12 Chinese
第一届监事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 15th meeting of the first Supervisory Board of Shenzhen Huitai Medical Devices Co., Ltd. It details decisions regarding adjustments to the 2021 restricted stock incentive plan and the granting of reserved restricted stocks to incentive recipients. The document includes voting results and references related announcements published on the Shanghai Stock Exchange website. The content focuses on supervisory board meeting resolutions about stock incentive plans, not on financial results, audit opinions, or management changes. It is not a full report but an official meeting resolution announcement. Therefore, it fits best under Regulatory Filings (RNS) as a formal regulatory announcement that does not fit other specific categories like MANG or CAP.
2022-04-12 Chinese
独立董事关于第一届董事会第十七次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on proposals discussed at the 17th meeting of the first board of directors of Shenzhen Huitai Medical Devices Co., Ltd. It discusses adjustments to a 2021 restricted stock incentive plan and the granting of reserved restricted stocks to incentive recipients. The document is a formal opinion letter from independent directors regarding board meeting proposals, focusing on governance and compliance with laws and company regulations. It does not contain financial statements, earnings data, or detailed financial analysis. It is not an announcement of voting results or a proxy solicitation. It is not a full annual or interim report, nor an earnings release. The document is best classified as Board/Management Information (MANG) because it relates to board meeting matters and decisions about management incentives and governance.
2022-04-12 Chinese
第一届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Shenzhen Huitai Medical Devices Co., Ltd. It details decisions about adjustments to a 2021 restricted stock incentive plan and the granting of reserved restricted stock to eligible recipients. The document includes voting results and references to related announcements published on the Shanghai Stock Exchange website. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is a board meeting resolution announcement related to management decisions on stock incentives, which fits the category of Board/Management Information (MANG). The document length is short (1793 characters), and it is not merely an announcement of a report but contains substantive board decisions. Therefore, the appropriate classification is MANG with high confidence.
2022-04-12 Chinese
关于向激励对象授予预留部分限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the granting of reserved restricted shares under a 2021 restricted stock incentive plan by Shenzhen Huitai Medical Devices Co., Ltd. It includes specifics about the number of shares, grant dates, prices, eligibility, approval procedures, legal opinions, and accounting treatment. The content focuses on the company's equity incentive plan and the allocation of shares to employees and management. This is not a financial report, earnings release, or management discussion, but rather a formal announcement about a capital change related to share issuance to incentive recipients. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the clear focus on share issuance under an equity incentive plan.
2022-04-12 Chinese
2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the implementation of the 2021 annual dividend distribution. It details the dividend per share, relevant dates (record date, ex-dividend date, payment date), tax treatment, and distribution methods. It references the approval of the dividend distribution at the 2021 annual shareholders meeting held on March 31, 2022. The document is relatively short (2784 characters) and focuses solely on the dividend distribution details without containing full financial statements or comprehensive financial performance data. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2022-04-12 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.